Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse ...
Among measures taken, Roche said its Chief Diversity Offices in the U.S. and at its Basel headquarters "will focus on ...
Swiss pharmaceutical giant Roche is cutting its global diversity workforce targets, aligning with recent U.S. legal changes ...
New Evrysdi five-year data from the SUNFISH study showed continued stabilisation of motor function in a broad population of ...
Swiss pharmaceutical giants Roche and Novartis are revising their diversity policies in response to recent U.S. executive ...
Roche Holding AG scrapped long-held global diversity targets for its leadership, showing how pressure from the Trump administration is causing companies to back away from DEI policies outside the US.
It’s not just American companies rethinking their diversity, equity, and inclusion (DEI) initiatives. Swiss pharma giants ...
Roche (ROG.S), opens new tab said its Chief Diversity Offices in the U.S. and at its Basel headquarters "will focus on inclusion and belonging, and responsibilities will be re-scoped accordingly".
Tecsys Inc. , a global leader in supply chain management solutions, announced that Roche, the world's largest biotechnology company and global leader in in-vitro diagnostics, has selected Tecsys' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results